• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Teleflex has a serious breathing circuit bacterial filters recall

Teleflex has a serious breathing circuit bacterial filters recall

November 3, 2022 By Danielle Kirsh

Teleflex Iso Gard Filter SThe FDA this week said the Teleflex (NYSE:TFX) recall of some Gibeck Iso-Gard bacterial and viral filters is a Class I recall, the most serious kind.

Teleflex is recalling several types of the Iso-Gard Filter S after receiving reports that the filter may split or become detached from breathing systems.

Iso-Gard Filter S filters are used as breathing circuit bacterial filters that are connected to respiratory equipment or breathing systems in intensive care units and operating rooms. They protect the equipment and the patients from potential airborne contaminants.

If the filter splits or detaches during use, the filter may not work properly and could cause a patient to receive an insufficient supply of air, with patient oxygen levels potentially dropping below safe levels. There is also a risk of cross-contamination.

The FDA said in a recall notice that using these devices could result in serious injury or death. So far, there have been 36 complaints and four injury reports related to the devices, including desaturation. There have been no reports of deaths or long-term injuries.

The recall involves 60,500 devices manufactured between Dec. 17, 2019 and March 26, 2022, that were distributed between Sept. 1, 2020 and July 5, 2022. Patients who receive care from breathing systems that use the Iso-Gard Filter S and healthcare professionals providing care for patients with the breathing systems that use the device are more at risk.

Products affected in the recall include:

Teleflex recall product codes and product names

Specific lots in the recall can be found in the FDA notification.

Teleflex is recommending medical facilities immediately check inventory for products within the recall scope and to stop using and distributing affected projects and quarantine those devices. The company will issue credit notes after receiving returned affected products.

Distributors should also provide a recall notice to all customers who received the product and have each customer complete an acknowledgment form and return the product to the distributor.

Filed Under: Featured, News Well, Recalls, Regulatory/Compliance, Respiratory Tagged With: Teleflex

More recent news

  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Philips prices $1.1B offering to pay off debt, finance green projects
  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy